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Abstract
Externally controllable drug delivery systems are crucial for a variety of drug delivery
applications where the dosage and timing of drug delivery needs to be adjusted based on
disease diagnosis and progression. Here, we have developed an externally controllable
drug delivery platform by combining three extensively used platforms: hydrogels,
liposomes, and single-walled carbon nanotubes (SWCNTs). We have developed carbon
nanotube-liposome complexes (CLCs) and incorporated these structures into a 3D
alginate hydrogel for use as an optically controlled drug delivery system. The CLC
structures were characterized using a variety of imaging and spectroscopic techniques
and an optimal SWCNT/lipid ratio was selected. The optimal CLCs were loaded with a
model drug (FITC-Dex), incorporated into a hydrogel, and their release profile was
studied. It was shown that release of the drug cargo can be triggered using an NIR laser
stimulation tuned to the optical resonance of a particular SWCNT species. It is further
shown that the amount of released cargo can be tuned by varying NIR stimulation time.
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This system demonstrates the externally controlled delivery of drug cargo and can be
used for different applications including cancer chemotherapy delivery.

Keywords biomaterials, nanotechnology, stimulated drug delivery, single-walled carbon
nanotubes, liposomes, hydrogels, self-assembly, near-infrared laser stimulation
Introduction
Externally controllable drug delivery systems are crucial for a variety of applications
including tissue engineering and cancer chemotherapy. Cancer is the 2nd leading cause
of death in the United States and affects 40% of Americans during the course of their
lifetimes. It is estimated that 4,950 new invasive cases will be diagnosed each day in the
United States in 2020.1 Although many chemotherapeutic drugs have been developed for
cancer, severe systematic toxicity of these drugs has limited their clinical usage. More
specifically, the most efficient systems can provide drug accumulation at tumor sites with
less than 1% efficiency, leaving 99% of the administered drug to adversely affect healthy
tissues.2 Delivery systems are therefore developed to increase the localized dose and
effectiveness of the chemotherapeutic drugs at the target sites.3-8 One of the most
challenging factors in developing these systems is designing a versatile system that can
be loaded with a variety of payloads rather than individually designed systems for a
specific payload. Traditionally, delivery systems for specific drugs were developed based
on modifications of the drug formulation or a chemical bonding of the drug to the drug
carrier. While these systems have shown promise for some applications, extensive
research is needed for the design of one drug delivery system applicable for one unique
drug making this design step a bottleneck in the process. There are a few different design
approaches that circumvent this issue by providing a platform for drug delivery.
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Hydrogels have been extensively studied and used for localized drug delivery due to their
biocompatibility, modifiable properties, and high drug loading capacity.9-12 The hydrogel
drug delivery systems often utilize degradation rate or other physical/chemical
parameters of the hydrogel scaffold as a tool to achieve a sustained and controlled
release rate. However, many cancer conditions require more complex controlled release
profiles (i.e. on-demand & real time control over release).4, 13, 14 Furthermore, conventional
hydrogel systems can only be used to deliver hydrophilic drugs, leaving out a major group
of drugs which are hydrophobic.

Stimuli responsive drug delivery systems are a class of materials developed to provide
real-time control over drug release. These stimuli can be biological in nature, such as pH,
temperature, and reactive oxygen species (ROS), or can be external, such as magnetic
field, ultrasound, electrical field, or light.11, 15-21 To develop an external stimuli responsive
system, a stimuli responsive moiety is often combined with a drug carrier moiety.
Therefore, when a stimulus is applied, the responsive moiety triggers a physical or
chemical change in the carrier moiety that leads to the drug release. Self-assembled
liposomes offer many adjustable parameters for developing controlled drug delivery
systems.22 Liposomes are often used as the drug carrier moiety as they can encapsulate
both hydrophilic and hydrophobic drugs.23, 24 There are many liposomal formulations that
are currently FDA-approved or are in clinical trials.25 One of the most important limitations
of liposomal drug delivery is their fast clearance and low retention. To address this
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limitation, liposome/hydrogel systems are developed. These systems can achieve longterm drug delivery while utilizing unique properties of both liposomes and hydrogels.26, 27
Single-walled carbon nanotubes (SWCNTs) are composed of a single graphitic layer
rolled up into a one-dimensional nanocylinder.28,

29

The existence of an electronic

bandgap energy in semiconducting SWCNTs results in a variety of unique near-infrared
(NIR) optical and electronic properties making them ideal candidates for various disparate
fields including photothermal therapy,30,

31

bioimaging,32,

33

biosensing34,

35

and drug

delivery.36-39 Their bandgap energies and chiral identities vary based on the roll-up
direction of the graphitic layer, resulting in various species (chiralities) that differentially
absorb photons with energies matching the band gap of the E 11 optical transition. These
wavelengths are in the biological tissue-transparency range, including NIR-I (750-1000
nm) and NIR-II windows (1000-1700 nm)28, which enables NIR-stimulated heating of
implanted SWCNTs. Various amphiphilic polymers such as short single stranded DNA
(ssDNA)

40-42

and Phospholipid-Polyethylene glycol (PL-PEG)

43

have been shown to

effectively wrap around the SWCNTs through noncovalent π-stacking of their
hydrophobic sections on the SWCNT sidewalls, resulting in enhanced biocompatibility
and long-term colloidal stability. Solubilized single- or multi-walled carbon nanotubes
(referred here as CNTs) have shown promise in a variety of biological applications. In
most drug delivery systems, three main methods are used to induce interactions between
the active compound (drug) and CNTs. The first method is to use a CNT mesh or bundle
and entrap the active compounds within the meshes. The second approach involves
functional attachment of the compound to exterior CNT walls and the last approach is
using CNT channels as nano-catheters.44 As CNTs are stimuli-responsive and in
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particular respond to NIR laser, they can also be used as a stimuli responsive moiety in
developing a drug delivery system. Here, liposomes are employed as triggerable drug
carriers to prevent passive release of the cargo. This is critical as liposomes offer unique
features as drug carriers such as compatibility with both hydrophilic and hydrophobic
drugs, biocompatibility, and tunability.

Herein, we have developed an external stimuli responsive drug release system based on
DNA-wrapped SWCNTs (DNA-SWCNTs) self-assembled onto model drug (FITC-Dex)containing liposomes (lip). We embedded the carbon nanotube-liposome complexes
(CLCs) into a 3D hydrogel matrix to fabricate an implantable, NIR-responsive, localized
drug release device (Schematic 1). Cationic liposomes were self-assembled with
negatively charged DNA-SWCNTs to form CLCs at varying SWCNT/lipid ratios. The
CLCs were characterized using dynamic light scattering (DLS), and transmission electron
microscopy (TEM). The structures with optimal conditions were encapsulated into
alginate hydrogels for enhanced stability and retention. The controlled localized drug
release was accomplished by selectively heating the (9,4)-SWCNT chirality using an NIR
laser at 1122 nm, which increased the permeability of the liposomal bilayer and led to the
stimulated release of CLCs’ cargo.
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Schematic 1. DNA wrapped single walled carbon nanotubes and liposomes are selfassembled to carbon nanotube liposome complexes (CLCs) by electrostatic forces and
encapsulated in a 3D hydrogel matrix. A. Nano-scale components of the system are shown:
anionic DNA-wrapped SWCNT and cationic liposomes. B. DNA-wrapped SWCNTs and
liposomes are mixed at different ratios using a syringe and static mixer and CLCs self-assemble
at this step. C. CLCs are then encapsulated into a covalently crosslinked alginate hydrogel.

Methods
Materials Polycarbonate membranes (pore size 100 nm), filter supports, 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC); 2-dioleoyl-3-trimethylammonium-propane (DOTAP)
in chloroform were purchased from Avanti Polar Lipids Inc. (AL, US). Raw powder
SWCNTs produced by HiPco process were purchased from Nanointegris (QC, Canada).
Sodium Alginate (Protanal LF20/40) of high molecular weight ( 250 kDa) was provided
by FMC BioPolymers (Philadelphia, PA). Phosphate buffered saline (PBS) powder, NaCl,
2-(N-Morpholino)ethanesulfonic acid hydrate (MES hydrate), adipic acid dihydrazide
(AAD), 1-hydroxybenzotriazole (HOBt), 1-ethyl-3-(dimethylaminopropyl), carbodiimide
(EDC), Sigmacote solution and Fluorescein Isothiocyanate-Dextran (FITC-Dex MW of 3
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kDa) were purchased from Sigma Aldrich (MO, US). Desalted ss(GT)15 oligomeric DNA
and Cy5-ss(GT)15 were purchased from Integrated DNA Technologies (IA, US).
Preparation of DNA-SWCNT Dispersions Single-stranded DNA was used to noncovalently wrap the SWCNTs and disperse them in aqueous solutions following a
previously published method.33 For each dispersion, 1 mg of raw HiPco nanotubes was
added to 2 mg of desalted ss(GT)15 oligonucleotide in a microcentrifuge tube with 1 mL
of 100 mM NaCl. The mixtures were then ultrasonicated using a 1/8″ tapered microtip
(Sonics Vibracell) for 2 h at 40% amplitude, with an average power output of 8 W, in a 0
°C

temperature-controlled

microcentrifuge

tube

holder.

The

dispersion

was

ultracentrifuged (Sorvall Discovery M120 SE) for 30 min at 250,000 xg and the top 80%
of the supernatant was extracted. The concentration of the stock DNA-SWCNT dispersion
(SWCNT solution) was determined by a previously described method. This was done by
measuring the stock solution absorbance with a UV/vis/NIR spectrophotometer (Jasco,
Japan) at 910 nm and using the extinction coefficient Abs910nm = 0.02554 L mg-1 cm-1.42, 4547

To remove free DNA molecules, Amicon ultracentrifuge filters (Millipore Sigma) with

100 kDa molecular weight cutoff were used. Filtration was repeated three times for each
sample, and at each step, the pellets were resuspended in 100 mM NaCl.
Liposome Fabrication & Characterization Thin lipid film hydration method48 was used
to form DOPC:DOTAP 1:1 liposomes. Briefly, lipids were mixed at 1:1 molar ratio in
chloroform at 40 mM total lipid and rotary evaporated (rotavapor R-215 Buchi) in a 50 mL
round bottom flask to form a thin lipid film. The pressure was decreased from 300 mbar
to 200 mbar, and finally to 50 mbar (30 min at each pressure). During this step, the
rotating flask was kept in a water bath at 50 C. After the thin lipid film formation step,
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flasks were kept under vacuum (25 mbar) overnight for complete drying. Then, 4 mL of
the model drug solution (3 kDa FITC-Dex in deionized (DI) water) at 1 mg/mL was added
to each flask. After 5 min of hydration at 45 C, flasks were vortexed, and solutions were
extruded at room temperature through a polycarbonate membrane (100 nm pores) using
Avanti Extrusion System to form uniform-sized of unilamellar liposomes. Dynamic light
scattering (DLS) was used to measure the size and polydispersity index (PDI) of the final
liposome solution.
SWCNT-Liposome Complex (CLC) Fabrication and Characterization DNA-SWCNTs
(at 0, 20, 50 or 100 mg/L) were mixed with FITC-Dex-loaded liposomes (at 5 mM of lipid
concentration). A syringe pump (NE Pump System Model NE-4000) and a two-barrel
syringe were used to keep the mixing rate constant and ensure complete mixing of the
SWCNT and liposome solutions. The samples and SWCNT solution were then analyzed
using DLS to measure size, PDI, and zeta-potential. Cryo-transition electron microscopy
(cryo-TEM) was conducted using a JEOL JEM-2100F TEM (Ma, US). It was operated at
200 kV using a liquid nitrogen cooling stage Model 915, Gatan Inc. (CA, US). 10 mL of
the sample was deposited onto a Quantfoil copper grid of 200 square mesh purchased
from Electron Microscopy Sciences (PA, US). The sample grids were inserted in liquid
ethane using a Vitrobot system (FEI Company, Hillsboro).
Integration of CLCs into 3D Hydrogels & Passive Release Purified alginate was
dissolved in MES buffer at 2.5 wt% with 2.5 mM AAD crosslinker and 4.3 mM HOBt. The
alginate solution (2 mL) was then mixed with CLCs at 2.5 mM lipid and 25 mg/L SWCNT
(2 mL) using luer-lock syringes and luer-lock connectors. To ensure complete mixing, at
least 20 passes were performed each time. EDC in MES buffer (1 mL) at 100 mg/mL was
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used to initiate crosslinking. Two silicone coated glass plates with 2 mm spacers were
used for gel casting. Individual cylindrical 8 mm2 mm gel disks were cut using biopsy
punches (Integra Miltex, PA). A three-day rinse (9 times media change) was performed
in PBS to remove any non-encapsulated drug and crosslinking residues. This rinsing step
was also used as a purification step to remove any free SWCNT from the system. The
gels were then kept in 24 well plates in 1 mL of PBS at room temperature in dark and
media was changed daily.
Gels were exposed to 0.02% Triton-X 100 (TX-100) solution to disrupt liposomes and
release their cargo on day 3. Samples were collected daily and confocal microscopy of
the hydrogels was performed at specific time points (day 3 and day 4) using laser
scanning microscopy with a Zeiss LSM 700 confocal module. Epifluorescence
observation with FITC filter was used with the diode laser with an excitation line at 488
nm. Zeiss ZEN 2011 software was utilized for image analysis. 3D z-stacks of xyz (350
µm ´350 µm ´250 µm) was obtained using 10 µm step size at day 0 to ensure uniform
distribution of CLCs within the hydrogel with different SWCNT concentrations. To quantify
FITC-Dex release, fluorescence spectra of the samples was measured using Cytation 3
Plate Reader with BioTek Gen5 software using the excitation wavelength of 490 nm and
the emission wavelength of 520 nm. Standard solutions were prepared with known
concentrations of FITC-Dex and the standard curve was used for calculating unknown
concentrations.
As SWCNTs can affect fluorescence properties of dyes, we performed a control test
where different concentrations of DNA functionalized SWCNTs were mixed with a
constant concentration of FITC-Dextran and incubated at room temperature for 1 h.
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Examined concentrations were 20 mg/L, 10 mg/L and 5 mg/L SWCNT in the final solution
with a constant FITC-Dex concentration of 1 mg/mL. A Cytation 3 Plate Reader with
BioTek Gen5 software was used and fluorescence emission spectra was measured using
excitation wavelength of 490 nm.
Colocalization of SWCNTs and Liposomes To study colocalization of SWCNT and
liposomes in CLCs, single stranded DNA was substituted with Cy5-ssDNA where a Cy5
dye was attached to 5’ end of the DNA strand. All of the other parts of the procedure were
followed similar to the previously described method: “DNA Wrapping of SWCNT”. These
Cy5-DNA-SWCNT were then used to fabricate CLCs at 50 mg/L. FITC-Dex 3 kDa at 0.5
mg/mL was loaded into the liposomes prior to mixing with SWCNTs. These CLCs were
then integrated into an alginate scaffold and rinsed for one day. Fluorescence confocal
microscopy was performed using a Zeiss LSM 700 confocal. Epifluorescence observation
with a Rhodamine filter with an excitation at 555 nm was followed with a FITC filter with
an excitation line at 488 nm. The middle image of the z-stack was used for colocalization
analysis. The images from these two channels were overlaid and colocalization analysis
was conducted with FIJI software using Coloc 2 plugin.
Confocal Raman Imaging Gels were imaged using a WiTec Alpha300 R confocal
Raman microscope (WiTec, Germany) equipped with a Zeiss EC Epiplan - Neofluar 10x
/0.25 objective, a 785 nm laser source set to 30mW sample power, and a WiTec UHTS
300 CCD detector with a 300 lines/mm grating. The Raman Z-stacks were obtained in 2.5
X 2.5 µm intervals with 17.5 µm depth between slices and a 0.2 second/spectrum
integration time to construct hyperspectral Raman volumes within the gels. A global
background subtraction and cosmic-ray removal was performed using WiTec Control 5.2
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software on all acquired confocal Raman data. A calibration curve was obtained by
recording spectra of known SWCNT concentrations serially diluted in a single pixel
volume using identical acquisition settings. Using custom Matlab codes, the G-band from
each spectrum was fit to a Lorentzian curve and the intensity was correlated to the known
SWCNT concentration to produce linear fit coefficients. The G-band of all spectra from
the confocal Raman Z-stacks were fit to Lorentzian curves, the intensity was extracted,
and the calibration coefficients were applied to construct 3D concentration maps of
SWCNTs in the gels.
Mechanical Testing of Hydrogels Compression tests were performed on hydrogels
using an Instron Model 3345 (Norwood, MA). Hydrogels were fabricated and fully swollen
in PBS for three days before the tests. The stress vs. strain of each gel (8 mm2 mm)
was recorded while the gel was compressed at a rate of 2 mm/min to up to 70% strain.
Three gels were tested for each condition. Young’s moduli were calculated using the initial
linear portion of the curve and the strain of failure was defined as the highest strain before
the failure (the drop in compressive stress).
SEM imaging of CLC and alginate gels CLC and alginate gels were imaged using
scanning electron microscopy to visualize gel’s porous structure. To prepare the samples
for SEM imaging, each gel was frozen at -20 ºC overnight. Gels were then lyophilized at
0.05 mbar and -50 ºC for one day. Gels were then cross sectioned using a sharp razor
blade, sputter coated by gold (coating thickness of 18 nm). Samples were imaged using
a Zeiss SIGMA VP field emission scanning electron microscope (FE-SEM). EverhartThornley detector was used with 3 kV acceleration voltage and chamber pressure was
set at 5 10-6 Torr.
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Heating of CLC Solutions using an NIR Laser We conducted all of the
heating/stimulating experiments using a laser module with fiber coupling at 1122 nm
(Model MIL-H-1122-1W) (Changchun New Industries, China). Samples were kept in a 24
well plate during the experiment (1 mL in each well). The laser was set up to have a 1 cm
distance from the well. A water bath was set at 37 ºC and plates were kept on the water
using a stand prior to starting of the experiment (to reach equilibrium) and during the
experiment. Four different SWCNT concentrations (0 , 10 , 20 and 30 mg/L) were heated
using the NIR laser at 8.85 kW/m2 . The temperature was recorded using a USB TC-08
thermocouple data logger (Pico Technology, UK) with 10 seconds time intervals. These
concentrations were selected because they correspond to the final concentration of
SWCNT in the gels using initial SWCNT concentrations of 0, 25, 50 and 75 mg/L. A pulsed
heating experiment was conducted using the 20 mg/L solution where the laser was set at
60 seconds on, 300 seconds off and the pulse was repeated 5 times.
Stimulated Release Studies CLCs were fabricated and loaded with 0.5 mg/mL FITCDex 3 kDa using the 50 mg/L SWCNT solution as described previously. Hydrogels were
fabricated following the previously described method with CLCs or liposomes. The
hydrogels were cut in 8 mm diameter 2 mm thick cylinders and rinsed 9 times in 3 days
prior to start of the experiment. Then, each gel was kept in a well of a 24 well plate with
1 mL PBS for release studies. One set of gels (n=3) were stimulated using the 1122 nm
laser at 8.85 kW/m2 at 37 °C for 1 h while another set of gels (control at 37 °C) were not
stimulated. One set of liposome gels (n=3) were exposed to 0.2% TX-100 solution to
release all of the liposome cargo. Release samples were acquired immediately before
and 1 day after stimulation (to provide enough time for diffusion from the gel). In another
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experiment, three sets of CLC encapsulating gels (control, stimulated and TX-100) were
tested for different time durations (15, 30 or 45 min). Samples were acquired immediately
before and after stimulation for all of the conditions. Although sampling right after
stimulation did not provide enough time for all of the drug released from CLCs to diffuse
out of the hydrogel, it aimed to show differences in instant release for the different NIR
stimulation time durations.
Swelling Ratio Measurement before and after NIR Stimulation Swelling ratio of CLC
gels was measured for two set of gels: 1. control CLC gels at 50 mg/L that were not
stimulated and 2. stimulated gels: exposed to NIR laser stimulation at 8.85 kW/m2 for 1
h. Gels were formed following the previously mentioned method and punched into
individual cylindrical disks (8 mm 2 mm). Each gel was fully swollen and rinsed 9 times
before the tests. The weights of the swollen gels were measured after removal of excess
solution by a filter paper. The gels were then frozen overnight at -20 °C and lyophilized at
0.05 mbar for a day. The weights of dry gels were measured right after their removal from
the lyophilizer. Swelling ratio (SR) was calculated using the following formula:
𝑆𝑅 =

𝑊𝑆 − 𝑊𝑑
𝑊𝑑

where 𝑊𝑠 and 𝑊𝑑 represent weights of the swollen and dried gels, respectively.
Cytotoxicity of CLC gels in vitro To assess gel and laser stimulation cytotoxicity in vitro,
Annexin V/ Propidium Iodide apoptosis assay was used on macrophages. RAW 264.7
TIB-71 cells (ATCC, Manassas, VA, USA) were cultured under standard incubation
conditions at 37 C and 5% CO2 in cell culture medium containing sterile filtered highglucose DMEM with 10% heat-inactivated FBS, 2.5% HEPES, 1% L-glutamine, 1%
penicillin/ streptomycin, and 0.2% amphotericin B. Media components were acquired from
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Gibco. RAW 264.7 macrophages were cultured until 80% confluency in 24-well plates, at
which media (1 mL) was replaced and CLC gels (8 mm diameter and 2 mm thick, rinsed
9 times) were added to each well. Gels were either stimulated using a 1122 nm laser at
8.85 kW/m2 or incubated without stimulation for 1 h. Cells were immediately collected
from each well and stained with annexin V and propidium iodide (Dead Cell Apoptosis Kit
V13242, Invitrogen) following the manufacturers protocol. Fluorescence images of the
stained cells were acquired using a Cellometer Vision CBA Image Cytometer (Nexcelom
Bioscience) and images were analyzed using ImageJ and custom MATLAB codes. Three
gel samples were used for each condition and total cells of n>6,700 were imaged in
histograms. Fluorescence data were gated based on control cells cultured without gel
addition. For this non-gel control, 4 well plates were used with total cells of n>6,700.
A gel from each group of stimulated or non-stimulated was imaged to capture any visual
or macroscopic physical changes.
Statistical Analyses and Data Representation All quantitative data are reported as
means ± standard deviation of three different samples. Analysis of variance (ANOVA)
was used with Tukey’s post hoc tests for multiple comparisons to evaluate statistically
significant differences when multiple groups were compared. When a single pair of
conditions were analyzed, Student’s t tests were used. p values less than 0.05 was the
benchmark for statistically significant differences. Symbols *, **, and *** indicate statistical
significance with p < 0.05, 0.01, and 0.001, respectively. No statistically significant
difference is indicated by an “n.s.” (p > 0.05).

Results & Discussion
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SWCNT-Liposome Complex (CLC) Fabrication
We fabricated SWCNT-liposome complexes (CLCs) through self-assembly by mixing
DNA-functionalized SWCNTs with cationic liposomes. To study the effect of SWCNT
solution concentration on the CLCs’ structures, four different concentrations of SWCNT
solution were tested: 0, 20, 50 and 100 mg/L. We used a previously published method33
to achieve uniformly dispersed solutions of Hipco SWCNTs. In their raw form, SWCNTs
are highly hydrophobic and are insoluble in water. Sonication of SWCNTs with DNA and
ultracentrifugation to remove aggregates results in a dark, ink-like solution of dispersed
DNA-SWCNT conjugates. Successful conjugation is further confirmed by the appearance
of multiple peaks in the NIR and visible range of their absorbance spectrum 41, 42 (Figure
S1). As shown in Figure 1A, the average diameter of the liposomes did not change
significantly when the 20 mg/L SWCNT solution was introduced. However, when the
SWCNT solution’s concentration was increased to 50 mg/L and 100 mg/L, the average
diameter significantly changed compared to the lower concentrations as well as
compared to the bare liposome (i.e. 0 mg/L) (Figure 1A(i), black bars). It is important to
note that the polydispersity index also did not change significantly when 20 mg/L of
SWCNTs were used. The polydispersity index increased significantly compared to the
bare liposomes (i.e. 0 mg/L) when 50 mg/L or 100 mg/L SWCNT solutions were used
(Figure 1A(i), green bars). Zeta potentials of the CLC solutions were also measured, and
a decreasing trend was observed as the SWCNT concentration increased. The zeta
potential of SWCNT solution at 50 mg/L was -39.8 mV with standard deviation of 5.57.
Similar to diameter and PDI, no significant changes were noticed when zeta potential of
20 mg/L was compared with the control (i.e. 0 mg/L). However, zeta potential of CLCs at
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50 mg/L and 100 mg/L was significantly decreased compared to the control. Despite this
decrease and significant change, the value of the zeta potential stayed positive. This can
be attributed to the positive charge of the head groups of DOTAP lipids which are used
in the fabrication of the self-assembled liposomes. As the DNA functionalized SWCNTs
have a negative charge, they are electrostatically attracted to these positively charged
lipids and form self-assembled CLCs. SWCNTs partially coated the liposomes and as a
result led to partial charge screening of cationic DOTAP headgroups; however, they did
not change the total charge of the solution to a negative value. When the concentration
of SWCNTs was increased further (e.g. 200 mg/L), macroscopic aggregations formed,
and the solution was unstable. The net positive charge of CLCs is desirable as it facilitates
their prolonged encapsulation within the 3D alginate hydrogel which is a negatively
charged polymer and limits leakage of CLCs out of the hydrogel. It was concluded that
the structures of CLCs were defined mainly by the ratio of SWCNTs to liposomes and
therefore by changing the SWCNT’s solution concentrations while keeping liposome’s
solution concentration constant, different complexes were formed.

Cryo-TEM imaging was performed to visualize the CLC structures at 50 and 100 mg/L
SWCNT concentrations. As shown in Figure 1B, complex and abnormal shapes were
observed at 50 mg/L and 100 mg/L compared to the regular unilamellar liposomes at 0
mg/L (the left image). As SWCNTs have very low contrast in cryo-TEM imaging, single
SWCNTs cannot be directly observed but are rather detected by the effects that they
apply on other higher contrast moieties (e.g. liposomes).41 Although these structures were
complex in shape, they still demonstrated characteristic liposomal bilayers and did not
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show macro aggregation when analyzed by DLS. This indicates that SWCNTs were not
disrupting the bilayers, signifying the preservation of liposomal integrity and the ability to
encapsulate drugs. This was further verified in drug release experiments.

A

(i)

(ii)

*
n.s.

*
*
n.s.

SWCNT
concentration(mg/L)
(mg/L)
SWCNTinitial
Initial Concentration

B

liposome only

**

Zeta potential(mV)
potential (mV)
zeta

**
n.s.

Polydispersity index (PDI)

(nm)
average
Diameter (nm)
Average diameter

*

SWCNT Initial Concentration (mg/L)

SWCNT initial concentration (mg/L)

liposome + SWCNT at 50 mg/L

liposome + SWCNT at 100 mg/L

200 nm

Figure 1. CLCs with different properties (size and charge) are formed by changing
SWCNT to lipid ratio A. (i) Statistical comparison of average diameters and PDIs for
different CLCs. (ii) Statistical comparison of zeta potentials for different CLCs. B. Cryo-TEM
images of liposomes and CLCs at 50 mg/L and 100 mg/L are shown (n=3).

Integration of CLCs into 3D Hydrogels & Passive Release
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The fabricated CLCs were integrated into 3D alginate hydrogels to enhance stability and
enable on-demand localized drug delivery. CLCs in gels were imaged using confocal
fluorescence microscopy for all formulations (Figure 2A). The 3D z-stack of images at day
2 showed uniform distributions of CLCs in the 3D hydrogels (Figure S2). We confirmed
that FITC-Dex did not interact with the SWCNTs and result in quenched fluorescence at
the specified concentrations (Figure S3). Cumulative passive release rates were less than
2% for all of the conditions before the addition of TX-100 (Figure 2B). It is important to
note that the rates of passive release for CLCs with 20 mg/L SWCNT was significantly
higher than the rate of passive release for bare liposome (0 mg/L) in the first two day
(Figure 2C(i)). The passive release rate of concentrations 50 mg/L and 100 mg/L was not
significantly different from bare liposome in the first 2 days. This result can be explained
considering high PDI at 20 mg/L and complex shapes of CLCs that could lead to
significantly higher leakage rates. As the TX-100 solution was added to disrupt the
liposomal structures, enhanced release was observed for all of the conditions (Figure
2A&B). Although this enhanced release rate was slightly higher for 50 mg/L and 100 mg/L
SWCNT, no statistically significant differences were observed for these concentrations
compared to the lower concentrations (Figure 2C(ii)). Samples continued to release FITCDex from this time point (day 2) up to day 6. As the drug was released from the liposome
or CLC structures, some amount of the drug was trapped within the 3D hydrogel structure
(day 2 to day 6) and was slowly released through a constrained diffusion process. This
slow diffusion for several days is crucial for some applications as a sustained release is
required rather than a burst release for these applications.49 These results suggest that
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this system can provide a sustained release starting at a delayed and controlled time point
(e.g. day 2 in this experiment or the time of stimulation for stimulated release).
The release of encapsulated therapeutic components inside of a hydrogel matrix can be
affected by swelling-dependent changes in diffusivity. Therefore, to understand any
effects of NIR stimulation on this property, we measured swelling ratio of two set of gels:
(1) control CLC gels at 50 mg/L that were not stimulated and (2) CLC gels exposed to
NIR laser stimulation at 8.85 kW/m2 for 1 h. A represented gel from each group was also
imaged to evaluate any physical changes caused by NIR stimulation (Figure S4A).
There were no significant differences between swelling ratios of control or NIR stimulated
gels (Figure S4B). This indicates that in the stimulated release studies, release of cargo
from gel would be caused by disruption of the CLC structures followed by diffusion of the
cargo from the gel.
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Figure 2. CLCs were integrated into 3D hydrogel structures and imaged using confocal
microscopy. A. Images of the middle layer (z=100 mm) of a z-stack for different CLCs in
alginate are shown before (day 2) and after (day 3) addition of 0.02% TX-100. B. Percentage
of cumulative FITC-Dex release vs. time from 50 mg/L CLC loaded in alginate hydrogels are
demonstrated. C. Statistical comparison of release rates of FITC-Dex from CLCs that were
made using different DNA-SWCNT concentrations before the addition of 0.02% TX-100 (day

20

0-2). (ii) Statistical comparison of release rates of FITC-Dex from CLCs that were made using
different DNA-SWCNT concentrations after the addition of 0.02% TX-100 (day 2-3) (n=4).

CLC Distribution in the 3D Hydrogel and Hydrogel Characterization
As shown in Figure 3A, the hydrogels were a uniform light gray color (CLC integrated gel,
“CLC gel”, compared to liposome only gel, “lip gel”) with no visual signs of aggregation.
This uniform gray color verified relatively even distribution of the CLCs within the 3D
hydrogel with no macroscopic aggregations. SEM imaging was used to visualize the
porous structure of control alginate gels and CLC gels and confirmed no noticeable
differences in porosity of these gels, indicating that CLC encapsulation did disturb the
covalent crosslinking process of the alginate gels (Figure 3B). The mechanical properties
of lip gels and CLC gels at 50 mg/L DNA-SWCNT were analyzed. As shown in Figure 3C,
compressive stress vs. strain was measured for the different gels. While CLC integrated
gels had similar Young’s moduli compared to liposome integrated gels (Figure 3D(i)); a
significantly higher strain of failure was recorded for CLC Gels compared to lip gels
(Figure 3D (ii)). This result is consistent with previous studies that showed enhancement
of mechanical properties upon the addition of SWCNTs,50 and has been attributed to
matrix-fiber stress transfer. Fiber length, aspect ratio, dispersion, and alignment
determine the reinforcement effectiveness. Specifically, it is important to have a dispersed
SWCNT in the polymer network to achieve efficient load transfer and enhanced
mechanical properties.51
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Figure 3. CLCs distribution in an alginate gel and mechanical properties are shown. A.
Photos of Lip-gel and CLC-gel (8 mm diameter 2 mm thick) at the DNA-SWCNT
concentration of 50 mg/L is shown. B. SEM images of control alginate gel and CLC gel
showed no significant differences in porous structure. C. Compressive stress vs. strain curve
for a representative CLC gel and a lip gel is demonstrated. D. (i) Statistical comparison of
Young’s modulus of CLC gels vs. lip gels is shown. (ii) Statistical comparison of the strain of
failure of CLC gels vs. lip gels are shown (n=3).

Colocalization of the SWCNTs and liposomes was examined by using confocal
fluorescence microscopy. SWCNTs were dispersed with a fluorescently-tagged Cy5-DNA
strand (red) and FITC-Dex (green) was used as the model drug loaded inside of the
liposomes. Imaging of the fluorescently-tagged CLC gels was performed to ensure that
these moieties are not separated when integrated into the hydrogel construct. Figure S5
shows an overlaid confocal image and a qualitative colocalization analysis graph
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corresponding to that image. Results showed an average 70% colocalization. To further
evaluate SWCNT distribution within the hydrogel, hydrogel volumes of 10 6 mm3 were
imaged using confocal Raman microscopy. The intensity of the G-band spectral feature,
which is linearly correlated to SWCNT concentration,33, 52, 53 was used to visualize the
localized SWCNT concentration within the gel and the volumetric concentration of
SWCNTs in the gel was determined (Figure 4). A representative Raman Spectra of
SWCNT at a random layer and the average of Raman Spectra of all layers are shown in
Figure S6. There were no significant differences between the average Raman spectra
and the single layer Raman spectra.

Figure 4. 3D confocal Raman concentration map of SWCNT G-band intensity represents
localized SWCNT concentrations within a CLC integrated hydrogel (initial 50 mg/L) and the
volumetric concentration of SWCNTs in the gels is calculated(n=5).

Heating of CLC Solutions using an NIR Laser

23

To evaluate the heating efficiency of the CLCs at specified wavelengths, absorbance
spectra were acquired (Figure 5A). As expected, absorbance increased with SWCNT
solution concentration and several distinct peaks, each representing a distinct SWCNT
chirality,40, 47 were observed in the NIR range (Figure S1). For instance, the measured
spectra confirm the presence of chiralities of (9,4), (8,6) and (8,7)-SWCNTs in these
samples. While some methods are available to separate single chiralities of SWCNTs,
the efficiency of these separation processes are often very low.54 Here, we focused on
the most pronounced peak, i.e. the (9,4)-SWCNT ~1125 nm. It is important to note that a
peak around 1200 was also observed (the (8,6)-SWCNT). However, as the deionized
water (DI) absorption is also significantly higher at this wavelength (pink line), it was not
chosen for stimulation experiments.
We next examined the rate of heating of the SWCNT solutions due to laser illumination.
A 1 W total power 1122 nm laser (8.85 kW/m2) was used for all heating experiments with
the distance between samples and the laser tip held constant at 1 cm. All experiments
were conducted in a 37 C water bath. As shown in Figure 5B(i), by increasing SWCNT
concentration, T(°C) vs. time increased. The maximum T’s were compared for the
different SWCNT concentrations and a statistically higher maximum T(°C) was obtained
for a higher SWCNT concentration compared to a lower concentration (Figure 5B(ii)). To
understand the kinetics of the heating dissipation phenomena, a pulsed heating of 60
seconds on, 300 seconds off was applied on the SWCNT solution at 20 mg/L. As shown
in Figure 5C, the temperature reached 46 °C by the first 60 second laser pulse. However,
when the laser was turned off, the heat quickly dissipated, and the temperature
approached 37 °C in less than 300 seconds. This trend was repeated in the next on and
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off cycles. Quantification of average slopes of heating and cooling was conducted and
verified similar heating and cooling for all of the cycles (Figure S7).

Figure 5. Absorbance spectra and heating rate of CLCs are demonstrated. A.
Absorbance spectra of CLCs at different SWCNT concentrations. B. (i) ∆T (°C) of SWCNT
solutions vs. time at different concentrations are shown for 100 seconds heating at 1122 nm,
1 W. (ii) Statistical comparison of maximum ∆T (°C) for different SWCNT concentrations. C.
Temperature vs. time is shown for pulsed heating (60 seconds on, 300 seconds off) for the
SWCNT solution at 20 mg/L (n=3).
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Stimulated Release Studies
Finally, we demonstrated the stimulated release of FITC-Dex (3 kDa) from CLCs in a
hydrogel using an 1122 nm laser. CLCs at 50 mg/L SWCNT were used for all of the
stimulated experiments for CLC encapsulated gels. As shown in Figure 5A, each gel was
stimulated at 1 W using an 1122 nm laser for 1 h and its release was compared to a
control (same gel with no stimulation). Significantly higher amounts of FITC-Dex (3 kDa)
were released from the laser stimulated gels compared to non-stimulated control gels
(red bar compared with blue bar in Figure 5A(ii)). Release from liposome-encapsulated
gels (with no SWCNT) was also measured and no significant difference was noticed for
release from liposomes in gels with or without stimulation (purple bar compared with
green bar). Tx-100 solution was used as a positive control to release all the cargo (black
bar in Figure 5A(ii)). This experiment shows that 1 h of stimulation at 1122 nm leads to
release rates comparable with release from gels exposed to Tx-100 and suggests that
shorter stimulation durations can be used to stimulate release from CLCs in gel. To
understand the effect of stimulation duration on release, a few different and shorter
stimulation times were applied (i.e. 15, 30 and 45 min) on CLC gels with three different
conditions: control, stimulated and TX-100.
Adding 0.02% TX-100 solution to the gels resulted in significantly higher release rates
compared to control or stimulated gels for all the stimulation durations (Figure 5B, black
bars compared to blue and red bars). This significantly higher release rate was expected
as TX-100 disrupts the liposomal bilayers and leads to a total release of the encapsulated
drug. While different durations did not have a significant effect on the release rate from
the control group, the longest stimulation time (45 min) had a significantly higher release
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rate compared to the shorter stimulation times (30 min and 15 min). Although there was
not a significant difference between the release of 15 min and 30 min stimulations, 30 min
stimulation caused slightly higher release compared to the 15 min stimulation and there
does appear to be a manifest trend of increased release vs. NIR stimulation duration
(Figure 5B(ii): upward “stairstep” vs. duration). Thus, it may be possible to externally
regulate the amount of drug release from these structures through the duration of NIR
stimulation. Additionally, while not demonstrated here, laser could also provide a means
to externally regulate the amount of delivered payload triggered by stimulation events. It
is of note that all of the stimulations used here caused a bulk temperature increase of less
than 4 C (keeping the bulk temperature below 42 C). This could significantly prevent
tissue damage from heating and could also help preserve the bioactivity of encapsulated
and delivered payloads. It is known that bulk temperatures of more than 42 C (i.e. 46 C
or 49 C) can lead to permanent cell damage and cause tissue toxicity.55 If desired, the
CLC gel system can be modified to show a combined photothermal therapy and
chemotherapeutic delivery for cancer therapy.
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Figure 6. FITC-Dex release from CLCs in alginate hydrogels could be stimulated using
NIR laser. A. (i) Cumulative FITC-Dex release when 1 h stimulation at 1122 nm and 1 W was
applied. (ii) Statistical comparison of release rate for control and stimulated (1122 nm for 1 h)
Lip, CLC and TX-100 samples in hydrogel. B. (i) The release rate for the control, stimulated
and TX-100 CLC in hydrogel with different stimulation times is demonstrated. (ii) Statistical
comparison of release rate for the stimulated CLCs in hydrogels of different stimulation
durations is shown (n=3).
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Cytotoxicity of CLC gels in vitro
One of the concerns with photothermally induced drug delivery systems is that they can
cause side effects and toxicity to the tissue if the power intensity or temperature
increase is too high. Moreover, SWCNTs have a high binding capacity to biological
molecules, and if leaching from the gel occurs, can interact with live cells. Macrophages
would be the first line of defense in such a scenario.56 Therefore, RAW 264.7
macrophages were selected as the cell line to examine potential adverse effects from
the stimulated system. To assess toxicity effects of the gel itself and gel with 1 h NIR
stimulation, Annexin V/ Propidium Iodide apoptosis assay was used. Two-dimensional
scatter plots were created to display the results of these assays (Figure 7). In these
graphs, viable cells are shown at the bottom-left quadrant. The top-right quadrant shows
necrotic cells, bottom-right quadrant shows apoptotic cells and top-left quadrant shows
debris and cell junk. As there is not a significant difference between the necrotic and
apoptotic cells for the different conditions, it can be concluded that the gels and NIR
stimulation have minimal toxicity effects on macrophages in vitro. To assess the
cytotoxicity of this system further, other cell lines in vitro and in vivo animal models
should be used.
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Figure 7. Cytotoxicity assays of macrophages exposed to CLC gels with or without NIR
stimulation. A. Two-dimensional scatter of control cells not exposed to CLC gels or
stimulation. B. Cells exposed to CLC gels with no stimulation. C. Cells exposed to CLC gels
and stimulated with 1122 nm laser at 8.85 kW/m2 for 1 h.

Conclusion
In this study, we developed SWCNT-liposome complexes (CLC) for controlled triggered
release. It was shown that the CLC structure is defined by the SWCNT/lipid ratio and an
optimal ratio was selected for triggered release. Then, CLCs were integrated within a
3D hydrogel and it was shown that a model drug (FITC-Dex) can be retained for several
days. Furthermore, an NIR laser was used to stimulate release of the model drug from
the CLCs in the hydrogel scaffold. It was shown that stimulation time can be modified to
modify the amount of drug release. To understand the cytotoxicity effects of CLC and
NIR stimulation, Annexin V/ Propidium Iodide apoptosis assay was used on RAW 264.7
macrophages and minimal toxicity was noticed in vitro. Further studies need to be
conducted to investigate the application of this drug delivery system for delivering
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specific cancer chemotherapeutics at delayed time points and in vivo application of this
drug delivery system.
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